BioLine Rx Vs. Can Fite Biofarma Industry Stock Comparison

Sell

28

BLRX
BioLine Rx

Last Price:

0.65

Seasonality Move:

-5.08%

Sell

42

CANF
Can Fite Biofarma

Last Price:

2.04

Seasonality Move:

6.52%

Sell

28

BioLine Rx (BLRX) is a Sell

Is BioLine Rx a Buy, Sell or Hold?

The current BioLine Rx [BLRX] share price is $0.62. The Score for BLRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
BLRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

42

Can Fite Biofarma (CANF) is a Sell

Is Can Fite Biofarma a Buy, Sell or Hold?

The current Can Fite Biofarma [CANF] share price is $2.15. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BLRX Stock Price Chart

What is BioLine Rx's stock price today?

The BioLine Rx share price today is $0.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing slight selling pressure.

CANF Stock Price Chart

What is Can Fite Biofarma's stock price today?

The Can Fite Biofarma share price today is $2.15
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.

BLRX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.02	Sell
Relative Strength Index (14 RSI):	42.57	Sell
Chaikin Money Flow:	-18048	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.61 - 0.73)	Sell
Bollinger Bands (100):	(0.6 - 0.76)	Sell

CANF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.11	Sell
Relative Strength Index (14 RSI):	38.23	Sell
Chaikin Money Flow:	5846	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(2.23 - 2.45)	Sell
Bollinger Bands (100):	(2.12 - 3.14)	Sell

BLRX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.63	Sell
20-day SMA:	0.65	Sell
50-day SMA:	0.71	Sell
200-day SMA:	0.95	Sell
8-day EMA:	0.63	Sell
20-day EMA:	0.65	Sell
50-day EMA:	0.68	Sell
200-day EMA:	0.89	Sell

CANF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	2.3	Sell
20-day SMA:	2.3	Sell
50-day SMA:	2.79	Sell
200-day SMA:	2.37	Sell
8-day EMA:	2.27	Sell
20-day EMA:	2.35	Sell
50-day EMA:	2.54	Sell
200-day EMA:	2.6	Sell

BioLine Rx Earnings Growth & BLRX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.03 per share, an increase this year of $0.74 per share, and a decrease next year of $0.10 per share.

Can Fite Biofarma Earnings Growth & CANF Earnings Dates

Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.

BioLine Rx Technical Analysis

	Sep 5	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18
	Sep
	05	06	09	10	11	12	13	16	17	18
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Can Fite Biofarma Technical Analysis

	Sep 5	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18
	Sep
	05	06	09	10	11	12	13	16	17	18
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):